Pacific Bio (PACB) Tops Q2 EPS by 4c

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $39.8 million versus the consensus estimate of $36.66 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%
• SPS Commerce hires Morgan Stanley, explores sale - Reuters